semaglutide and belching Burping: Why It Happens 7 Ways to Reduce It Sulphur Burps from GLP-1 Injections

Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related comorbidities, and in adolescents aged 12 years and older with obesity

These guidelines apply to the general adult population, and individuals taking Wegovy should consider adhering to the lower end of these recommendations , particularly during the initial titration phase when side effects are most pronounced

Then pull back on the plunger to withdraw the correct amount of medication

The tirzepatide versus semaglutide dosage chart provides a direct dose-equivalency comparison if you are considering a switch

Aim for 7 to 9 hours of sleep per night, as inadequate rest can lead to higher blood pressure